ABSORB II Randomized Controlled Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 501 participants.

Also called NCT01425281

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 501 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01425281
Other papers using this trial's data
  • Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents Journal of the American College of Cardiology, 2017-07-04 DOI, PubMed 28662808
  • Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial Lancet (London, England), 2016-11-19 DOI, PubMed 27806897 PubMed links an erratum for this paper. Erratum: PMID 28248178

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01425281. Randomized; single masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2016-07 (actual). Results posted on 2019-09-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ABSORB II Randomized Controlled Trial
Acronym
ABSORB II
Intervention (Device)
Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
Intervention (Device)
Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01425281
Content hash
dd1b83bfb5e4af802a33f111020a3889891c46b89748f3de77c1de1ed44daeca